Subscribe today!
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Infographics
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Infographics
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Subscribe!
Subscribe Today!
Home
/
Tags
/
cancer cell resistance
cancer cell resistance
| 2 min read
by
Andrea Corona
Microbes inside tumors reveal new drug targets and resistance mechanisms
Researchers highlight how intra-tumoral microbiota shape tumor growth, drug resistance, and treatment response.
News
| 3 min read
by
Allison Whitten, PhD
Novel approach could overcome resistance to treatment in deadliest leukemia
A new study showed that adding a drug to inhibit the OPA1 protein could reverse resistance to a frontline treatment in patients with AML.
News
| 6 min read
by
Stephanie DeMarco, PhD
Behind the podcast: Sounding off in a nuclear reactor
Take a look into the making of the DDN Dialogues podcast episode: From warhead to cancer-killer, the quest for more actinium-225.
Articles
| 10+ min read
by
Stephanie DeMarco, PhD
From warhead to cancer-killer, the quest for more actinium-225
Actinium-225 is a radioactive isotope that kills cancer cells with a burst of alpha particles, but it was difficult to make enough of it — until now.
Podcasts
Page 1 of 1 - 4 Total Items
1
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe
Sponsored
Outpacing cancer’s next move with faster vaccine production
Rapid DNA-to-mRNA workflows help scientists keep pace with rapidly evolving cancer through personalized vaccines.
Infographics
Harnessing a three-organ MPS model to assess drug and chemical safety
Understand how a human-relevant
in vitro
model can be used to improve next generation risk assessment (NGRA).
Webinars
Technology Guide: Assessing liver safety with microphysiological systems
Explore the role of microphysiological systems in advancing human-relevant liver toxicity testing and mechanistic evaluation.
Technology Guides
Latest Issue
Volume 21 • Issue 4 • December 2025
December 2025
December 2025 Issue
Explore this issue